Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03711747 · ClinicalTrials.gov registry record
Indications for Osteochondral Allograft Transplantation
A clinical trial of Ankle Injuries and Post-Traumatic Osteoarthritis of Ankle, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT03711747: Completed study of Ankle Injuries and Post-Traumatic Osteoarthritis of Ankle, sponsored by University of Missouri-Columbia.
NCT03711747 is a study of Ankle Injuries and Post-Traumatic Osteoarthritis of Ankle that has completed, run by University of Missouri-Columbia. The registered enrollment target is 10 participants, below the 107-participant average among 3 other Ankle Injuries trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03711747, a study of Ankle Injuries and Post-Traumatic Osteoarthritis of Ankle, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
With IRB approval, a prospective single-cohort clinical trial will be performed to assess safety and efficacy of total biologic arthroplasty of the ankle. With informed consent, patients (n=10) who require tibio-talar arthroplasty based on physical examination and diagnostic imaging will be enrolled. Primary criteria for inclusion will be Grade IV changes in the articular cartilage of the tibial plafond and/or talar dome as determined by physical examination, diagnostic imaging and/or arthroscopy by the attending surgeon. Exclusion criteria include acute injury to any other part of the affected lower extremity or inability to comply with the protocol. After enrollment, patients will undergo standard ankle radiography and complete assessments (described below). Size-matched (standard clinical methodology) MOPSTM allografts (Musculoskeletal Transplant Foundation, Edison, NJ) from the same donor will be obtained to treat the entire tibiotalar joint. The affected joint will be treated with OCA transplants using our current technique and instrumentation. Osteochondral grafts including MOPSTM OCAs are regulated under U.S. Food and Drug Administration (FDA) section 361 of the Public Health Service Act and 21 Code of Federal Regulation 1271 that defines human cells, tissues or cellular or tissue based products (HCT/P). Patients will follow a managed post-operative rehabilitation protocol that is standard for those that have had an osteochondral allograft to their ankle. Range of motion and patient-reported outcome measures (PROMs) including VAS pain score, AOFAS, and PROMIS Mobility as well as complete radiographs (XR) of the affected ankle will be obtained prior to surgery and at 6 weeks, 3 months, 6 months, and 12 months after surgery to evaluate healing, function and evidence for arthrosis. MRIs for cartilage composition (12 months after surgery, and serum and urine biomarkers for treatment monitoring (preop, 6 and 12 months after surgery) will be performed. We will d
Primary Outcome
Pain assessment which measures what a patient rates their pain between 0 and 10, with 0 being no pain, and 10 being the most pain
Conditions Studied
Interventions
- PROCEDURE Osteochondral allograft ankle
Study Locations (1)
Missouri
- Missouri Orthopaedic Institute - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2022-10-01 |
What the finished NCT03711747 record still lists
NCT03711747 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 107-participant average among 3 other Ankle Injuries trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Ankle Injuries appearing as the primary indexed condition, and to 1 intervention - of which Osteochondral allograft ankle is the first listed.
NCT03711747 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03711747 about?
NCT03711747 is a clinical study titled "Indications for Osteochondral Allograft Transplantation". With IRB approval, a prospective single-cohort clinical trial will be performed to assess safety and efficacy of total biologic arthroplasty of the ankle. With informed consent, patients (n=10) who require tibio-talar arthroplasty based on physical examination and diagnostic imaging will be enrolled...
What is the current status of trial NCT03711747?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-01-01. Estimated completion is 2022-10-01.
What conditions does trial NCT03711747 study?
This clinical trial studies the following conditions: Ankle Injuries, Post-Traumatic Osteoarthritis of Ankle, Ankle Osteoarthritis.
What interventions are being tested in trial NCT03711747?
The interventions under investigation include: Osteochondral allograft ankle (PROCEDURE).
Who is sponsoring clinical trial NCT03711747?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03711747 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ankle Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI